Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells-Reference-Cited by-同舟云学术

Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells

Published:2010-06-23 Issue:6 Volume:29 Page:1241-1252
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Lui Vivian Wai Yan,Lau Cecilia Pik Yuk,Ho KaKiu,Ng Margaret Heung Ling,Cheng Suk Hang,Tsao Sai-Wah,Tsang Chi Man,Lei Kenny Ieng Kit,Chan Anthony TC,Mok Tony Shu Kam

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-010-9470-y.pdf

Reference65 articles.

1. Anderson KE, Mack TM, Silverman DT (2006) Cancer of the pancreas. In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York, pp 721–762

2. Chan AT, Teo PM, Johnson PJ (2002) Nasopharyngeal carcinoma. Ann Oncol 13(7):1007–1015

3. Teo PM, Kwan WH, Lee WY et al (1996) Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 77(12):2423–2431

4. Lui VW, Wong EY, Ho Y et al (2009) STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro. Int J Cancer 125(8):1884–1893

5. Ma BB, Lui VW, Poon FF et al. (2009) Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response. Invest New Drugs.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer;Frontiers in Oncology;2022-06-15

2. Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein–Barr Virus Infection;Pathogens;2021-08-31

3. Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma;OncoTargets and Therapy;2021-04

4. Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma;Signal Transduction and Targeted Therapy;2020-10-23

5. Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation;BMC Cancer;2019-11-14